Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca2+ mobilization and ERK phosphorylation in healthy Japanese subjects

Autor: Morikawa, Yoichiro, Kato, Hisashi, Kashiwagi, Hirokazu, Nishiura, Nobuko, Akuta, Keigo, Honda, Shigenori, Kanakura, Yuzuru, Tomiyama, Yoshiaki

Publikováno v: In Thrombosis Research February 2018 162:44-52

Human CalDAG-GEFI deficiency increases bleeding and delays αIIbβ3 activation

Autor: Kato, Hisashi, Nakazawa, Yozo, Kurokawa, Yumi, Kashiwagi, Hirokazu, Morikawa, Yoichiro, Morita, Daisuke, Banno, Fumiaki, Honda, Shigenori, Kanakura, Yuzuru, Tomiyama, Yoshiaki

Publikováno v: In Blood 8 December 2016 128(23):2729-2733

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Case report and review of the literature of primary central nervous system lymphoma of the fourth ventricle.

Autor: Kojima Y; Department of Neurosurgery, Osaka Metropolitan University, Osaka, Japan., Nakajo K; Department of Neurosurgery, Osaka Metropolitan University, Osaka, Japan., Ichinose T; Department of Neurosurgery, Osaka Metropolitan University, Osaka, Japan., Morikawa Y; Department of Hematology, Sumitomo Hospital, Osaka, Japan., Osawa M; Department of Pathology, Osaka Metropolitan University, Osaka, Japan., Goto T; Department of Neurosurgery, Osaka Metropolitan University, Osaka, Japan.

Publikováno v: Surgical neurology international [Surg Neurol Int] 2022 Nov 11; Vol. 13, pp. 529. Date of Electronic Publication: 2022 Nov 11 (Print Publication: 2022).

Unexpected Complication of R-CHOP Chemotherapy: Rapidly Progressive Bronchiolitis Obliterans Syndrome.

Autor: Nozaki K; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan., Ezoe S; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan., Hamaguchi M; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan., Tsutsumi K; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan., Kusakabe S; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan., Morikawa Y; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan., Fujita J; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan., Fukushima K; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan., Maeda T; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan., Shibayama H; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan., Kumanogo A; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan., Kanakura Y; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.

Publikováno v: European journal of case reports in internal medicine [Eur J Case Rep Intern Med] 2019 Oct 28; Vol. 6 (11), pp. 001266. Date of Electronic Publication: 2019 Oct 28 (Print Publication: 2019).